about
Nitric oxide and peroxynitrite in health and diseaseSerelaxin for the treatment of acute heart failure: a review with a focus on end-organ protectionMore answers to the still unresolved question of nitrate toleranceThe nitric oxide pathway and possible therapeutic options in pre-eclampsiaDaily low-dose folic acid supplementation does not prevent nitroglycerin-induced nitric oxide synthase dysfunction and tolerance: a human in vivo study.Effects of subcutaneously infiltrated nitroglycerin on diameter, palpability, ease-of-puncture and pre-cannulation spasm of radial artery during transradial coronary angiographyNitrate tolerance and the links with endothelial dysfunction and oxidative stress.Intravenous nitroglycerin in the treatment of decompensated heart failure: potential benefits and limitations.Recent developments in nitric oxide donor drugs.Dissociation between superoxide accumulation and nitroglycerin-induced toleranceNitroglycerine causes mitochondrial reactive oxygen species production: in vitro mechanistic insightsAcute Heart Failure TreatmentCataract induction by administration of nitroglycerin in cardiac patients through imbalance in redox statusNon-hemodynamic effects of organic nitrates and the distinctive characteristics of pentaerithrityl tetranitrate.New biomaterials for the sustained release of nitric oxide: past, present and future.Role of antihypertensive drugs in arterial 'de-stiffening' and central pulsatile hemodynamics.Editor's Choice-Recent therapeutic trials on fluid removal and vasodilation in acute heart failure.Vasodilator Therapy: Nitrates and Nicorandil.Nitric oxide generating/releasing materials.Quercetin and its major metabolites selectively modulate cyclic GMP-dependent relaxations and associated tolerance in pig isolated coronary arteryRanolazine, a new antianginal drug.Nitrate tolerance, oxidative stress, and mitochondrial function: another worrisome chapter on the effects of organic nitrates.Nitroglycerin protects the endothelium from ischaemia and reperfusion: human mechanistic insight.Chronic nitrates blunt the effects of not only nitric oxide but also natriuretic peptides in cardiac myocytes.Chronic nitroglycerine administration reduces endothelial nitric oxide production in rabbit mesenteric resistance arteryIn vitro organic nitrate bioactivation to nitric oxide by recombinant aldehyde dehydrogenase 3A1.Reduced vascular reactivity after chronic nitroglycerine administration: EDHF mechanism is also downregulated.Characteristics of attenuated endothelium-dependent relaxation seen in rabbit intrapulmonary vein following chronic nitroglycerine administrationReduced hyperpolarization in endothelial cells of rabbit aortic valve following chronic nitroglycerine administration.Role of PKC in the attenuation of the cGMP-mediated relaxation of skinned resistance artery smooth muscle seen in glyceryl-trinitrate-tolerant rabbit.HNO/cGMP-dependent antihypertrophic actions of isopropylamine-NONOate in neonatal rat cardiomyocytes: potential therapeutic advantages of HNO over NO.Nitric oxide donation lowers blood pressure in adrenocorticotrophic hormone-induced hypertensive rats.Continuous therapy with transdermal nitroglycerin does not affect biomarkers of vascular inflammation and injury in healthy volunteers.Acute and chronic effects of glyceryl trinitrate therapy on insulin and glucose regulation in humans.Nicorandil and Long-acting Nitrates: Vasodilator Therapies for the Management of Chronic Stable Angina Pectoris
P2860
Q24645400-68AE2A5B-81BB-4B07-820D-B6B6F25D9282Q26740185-5E95A0CD-BB46-499F-9DD2-DA188B1CCAEFQ27012713-1BC95654-1D5C-41CA-AD8F-5353B5DE17EEQ34065261-E5DB3A5E-81C9-4F19-B361-1974C55333F0Q34338622-F608BCE4-7EA8-4F7B-8A3D-F03A592DF313Q35028552-11DE8915-C9E5-4C55-AC41-4CD3DA66D194Q35583191-EEA06D99-6FE6-495F-8079-1B2520319020Q36022963-88ECC3FD-9B07-4D00-96FA-4D1A3D9A327BQ36052815-4CEA95F3-BA8B-4E52-B257-6DA2AAD818A7Q36952696-42F4E164-0FB9-4C48-9607-BA6333DCFC0EQ37117993-EF3C5F0E-C45E-4E85-A3AA-902D997C3FA9Q37291720-B056F7DA-4800-4919-B4A9-65561EE693DFQ37302909-0D908F57-B582-4C0E-A7B0-4F44E5FA03D7Q37379932-7E93D14D-C7A4-4381-80BC-D33AFD591D6BQ37575595-D8FED877-AFA7-4F23-B3E8-17234CE40910Q38006018-36C2812A-62E7-49B7-923B-31308AAABCFCQ38270144-C8FDF651-EEEA-4097-8829-F7702F1AF5CAQ38867313-56C708DF-3C7D-4B61-AA21-9689B60EE3BBQ38910851-7E5F7096-DF7A-4DC0-854B-659D379D0728Q39253159-72C08020-EA9A-4AFD-8126-9E6EA2B8B8DAQ40409900-3D320C0E-92C6-441E-A5A2-89CC044CBFD2Q40483858-D6FFD1C6-8C24-43DB-8523-143015CEBA9EQ41124709-2F1B81DF-D8E5-4C98-B3F7-50C474AD1AE4Q41487694-5CC73C9E-B5ED-46D8-8723-4AB10411D96AQ41785754-63AEDC78-C507-442D-806F-B72B1EA9822BQ41879419-9CF8423A-8061-4127-A534-69C9C8219698Q41880904-EF55CF59-E94E-4B61-A53E-39BF7F0473BDQ42116829-11D165E4-63A1-449D-A218-7B1B57ECBB3EQ43054888-8C8B4EBB-B9CA-4D42-A30C-B6AD056A0A33Q43263113-11A1EA0D-B396-4D7F-A186-37E473EB3828Q43755565-96095F03-963C-4346-80CF-5E2BA86D2FA5Q45156548-03615C43-E2B5-4212-8A50-B6C10B9DBDE0Q45969587-5F48427B-5269-4033-81C8-8D55B1F9BDAFQ46405972-C1CCBC1A-1179-450E-B6B4-118CCE8769DDQ57495852-D6823416-0CEC-4255-A774-D942E7D9FC61
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Nitrate tolerance: a unifying hypothesis.
@ast
Nitrate tolerance: a unifying hypothesis.
@en
Nitrate tolerance: a unifying hypothesis.
@nl
type
label
Nitrate tolerance: a unifying hypothesis.
@ast
Nitrate tolerance: a unifying hypothesis.
@en
Nitrate tolerance: a unifying hypothesis.
@nl
prefLabel
Nitrate tolerance: a unifying hypothesis.
@ast
Nitrate tolerance: a unifying hypothesis.
@en
Nitrate tolerance: a unifying hypothesis.
@nl
P1433
P1476
Nitrate tolerance: a unifying hypothesis.
@en
P2093
John D Parker
Tommaso Gori
P304
P356
10.1161/01.CIR.0000036743.07406.53
P407
P577
2002-11-01T00:00:00Z